Servier India Ends Exclusive Medicine Deal – What It Means?

Servier India, a branch of a French pharma company, had given Entero Healthcare exclusive rights to distribute its blood pressure (anti-hypertensive) medicines. This meant only one company could sell these medicines to retailers and chemists across India. But this raised red flags. The All India Organisation of Chemists and Druggists (AIOCD) – which represents thousands of medical stores – said this could: ⚠️ Create a monopoly ⚠️ Reduce competition ⚠️ Cause medicine shortages ⚠️ Impact prices and availability After pressure from AIOCD, Servier cancelled this exclusive deal on May 26. It told its partners that it will now supply medicines through multiple distributors again — not just one. Why this matters: ✅ More distributors = better supply ✅ Less chance of shortages ✅ Fair pricing and healthy competition ✅ Protection of trade and consumer interest AIOCD welcomed the decision and said it sends a strong message to other companies: “Don’t harm the open market with unfair practices.” Bottom line: This move helps keep the medicine market fair, competitive, and stable — good for both chemists and patients.